246 related articles for article (PubMed ID: 20457483)
1. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.
Lapaire O; Shennan A; Stepan H
Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):122-9. PubMed ID: 20457483
[TBL] [Abstract][Full Text] [Related]
2. [The role of angiogenic factors in preeclampsia].
Alasztics B; Gullai N; Molvarec A; Rigó J
Orv Hetil; 2014 Nov; 155(47):1860-6. PubMed ID: 25403279
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio.
Verdonk K; Visser W; Russcher H; Danser AH; Steegers EA; van den Meiracker AH
Hypertension; 2012 Oct; 60(4):884-90. PubMed ID: 22892815
[No Abstract] [Full Text] [Related]
4. Emerging new biomarkers of preeclampsia.
Polsani S; Phipps E; Jim B
Adv Chronic Kidney Dis; 2013 May; 20(3):271-9. PubMed ID: 23928393
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
Unal ER; Robinson CJ; Johnson DD; Chang EY
Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
8. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
9. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
Woodham PC; Brittain JE; Baker AM; Long DL; Haeri S; Camargo CA; Boggess KA; Stuebe AM
Hypertension; 2011 Dec; 58(6):1120-5. PubMed ID: 21986503
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.
Vatten LJ; Eskild A; Nilsen TI; Jeansson S; Jenum PA; Staff AC
Am J Obstet Gynecol; 2007 Mar; 196(3):239.e1-6. PubMed ID: 17346536
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of preeclampsia in high-risk women.
Shaker OG; Shehata H
J Womens Health (Larchmt); 2011 Apr; 20(4):539-44. PubMed ID: 21413896
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic biomarkers in pregnancy: defining maternal and fetal health.
Rasmussen LG; Lykke JA; Staff AC
Acta Obstet Gynecol Scand; 2015 Aug; 94(8):820-32. PubMed ID: 25753566
[TBL] [Abstract][Full Text] [Related]
13. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
Petersen TM; Larsen T; Nielsen HJ
Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays.
Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
Am J Obstet Gynecol; 2011 Nov; 205(5):469.e1-8. PubMed ID: 21903191
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors for the prediction of preeclampsia in high-risk women.
Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
[TBL] [Abstract][Full Text] [Related]
16. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
17. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 are significantly related to PAPP-A levels.
Gruson D; Yuemo CD; Classen JF; Lepoutre T; Piquard N; Debiève F
Clin Chem Lab Med; 2013 Apr; 51(4):e49-51. PubMed ID: 23072855
[No Abstract] [Full Text] [Related]
18. Circulating angiogenic factors and preeclampsia.
Tsatsaris V; Goffin F; Foidart JM
N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904
[No Abstract] [Full Text] [Related]
19. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.
Crispi F; Domínguez C; Llurba E; Martín-Gallán P; Cabero L; Gratacós E
Am J Obstet Gynecol; 2006 Jul; 195(1):201-7. PubMed ID: 16545329
[TBL] [Abstract][Full Text] [Related]
20. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]